DK3517151T3 - Ekstrakorporal fjernelse af mikrovesikulære partikler - Google Patents

Ekstrakorporal fjernelse af mikrovesikulære partikler Download PDF

Info

Publication number
DK3517151T3
DK3517151T3 DK19161598.8T DK19161598T DK3517151T3 DK 3517151 T3 DK3517151 T3 DK 3517151T3 DK 19161598 T DK19161598 T DK 19161598T DK 3517151 T3 DK3517151 T3 DK 3517151T3
Authority
DK
Denmark
Prior art keywords
corporal
extra
removal
microvesicular particles
microvesicular
Prior art date
Application number
DK19161598.8T
Other languages
English (en)
Inventor
Thomas Ichim
Richard H Tullis
Original Assignee
Aethlon Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aethlon Medical Inc filed Critical Aethlon Medical Inc
Application granted granted Critical
Publication of DK3517151T3 publication Critical patent/DK3517151T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3496—Plasmapheresis; Leucopheresis; Lymphopheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/362—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits changing physical properties of target cells by binding them to added particles to facilitate their subsequent separation from other cells, e.g. immunoaffinity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK19161598.8T 2006-03-09 2007-03-09 Ekstrakorporal fjernelse af mikrovesikulære partikler DK3517151T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78094506P 2006-03-09 2006-03-09
EP07752778.6A EP1993600B1 (en) 2006-03-09 2007-03-09 Extracorporeal removal of microvesicular particles

Publications (1)

Publication Number Publication Date
DK3517151T3 true DK3517151T3 (da) 2021-07-12

Family

ID=38475607

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19161598.8T DK3517151T3 (da) 2006-03-09 2007-03-09 Ekstrakorporal fjernelse af mikrovesikulære partikler

Country Status (6)

Country Link
US (4) US8288172B2 (da)
EP (2) EP3517151B1 (da)
CA (2) CA2644855C (da)
DK (1) DK3517151T3 (da)
ES (2) ES2880460T3 (da)
WO (1) WO2007103572A2 (da)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004064608A2 (en) * 2003-01-17 2004-08-05 Aethlon Medical, Inc. Method for removal of viruses from blood by lectin affinity hemodialysis
DK3517151T3 (da) * 2006-03-09 2021-07-12 Aethlon Medical Inc Ekstrakorporal fjernelse af mikrovesikulære partikler
CA2733672C (en) * 2007-08-16 2018-09-11 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
US20100255514A1 (en) 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
EP2238079A4 (en) * 2007-12-27 2014-07-02 Aethlon Medical Inc METHOD AND APPARATUS FOR INCREASING CLAIRANCE RATES OF A CONTAMINANT DURING EXTRACORPOREAL TRAFFIC TREATMENT
KR101810799B1 (ko) * 2008-02-01 2017-12-19 더 제너럴 하스피탈 코포레이션 의학적 질환 및 병태의 진단, 예후, 및 치료에 있어서 미세소포체의 용도
US20110218512A1 (en) * 2008-06-03 2011-09-08 Aethlon Medical, Inc. Enhanced antiviral therapy methods and devices
US10545149B2 (en) 2008-10-06 2020-01-28 Morehouse School Of Medicine Detection of HIV-related proteins in urine
US9487837B2 (en) 2008-10-06 2016-11-08 Morehouse School Of Medicine Exosome-mediated diagnosis of hepatitis virus infections and diseases
US7888035B2 (en) 2008-10-30 2011-02-15 Caris Mpi, Inc. Methods for assessing RNA patterns
WO2010056337A2 (en) 2008-11-12 2010-05-20 Caris Mpi, Inc. Methods and systems of using exosomes for determining phenotypes
WO2010065765A2 (en) * 2008-12-04 2010-06-10 Aethlon Medical, Inc. Affinity capture of circulating biomarkers
US20130029339A1 (en) 2009-09-09 2013-01-31 The General Hospital Corporation Use of microvesicles in analyzing kras mutations
EP2475988B1 (en) 2009-09-09 2018-11-14 The General Hospital Corporation Use of microvesicles in analyzing nucleic acid profiles
EP2542696B1 (en) 2010-03-01 2016-09-28 Caris Life Sciences Switzerland Holdings GmbH Biomarkers for theranostics
JP2013526852A (ja) 2010-04-06 2013-06-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 疾患に対する循環バイオマーカー
ES2624284T3 (es) * 2010-07-07 2017-07-13 Aethlon Medical Inc Métodos para cuantificar exosomas
US20120046231A1 (en) * 2010-08-23 2012-02-23 Andre Francis Palmer Composition and process for synthesizing polymerized human serum albumin for applications in transfusion medicine
WO2012031008A2 (en) 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
CA2817111C (en) 2010-11-10 2019-03-05 Exosome Diagnostics, Inc. Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom
WO2012112865A2 (en) * 2011-02-17 2012-08-23 Cornell University Compositions and methods to prevent cell transformation and cancer metastasis
EP2495025A1 (en) 2011-03-04 2012-09-05 Fresenius Medical Care Deutschland GmbH Filter for the removal of micro-vesicles from biological fluids, methods and devices using such a filter
CA2835641C (en) * 2011-05-11 2019-05-28 Exosome Diagnostics, Inc. Nucleic acid extraction from heterogeneous biological materials
US9549953B2 (en) * 2011-12-08 2017-01-24 Eliaz Therapeutics, Inc. Galectin-3 plasmapheresis therapy
DE102012019088A1 (de) * 2012-09-28 2014-04-03 Orthogen Ag Antibakterielle Arzneimittelpräparate
KR101933621B1 (ko) 2012-09-28 2018-12-28 삼성전자주식회사 소포를 분리하기 위한 조성물, 키트 및 이를 이용하여 소포를 분리하는 방법
US10942184B2 (en) 2012-10-23 2021-03-09 Caris Science, Inc. Aptamers and uses thereof
EP2735326B1 (en) 2012-11-26 2017-03-08 Gambro Lundia AB Liver support system
PL2735360T3 (pl) 2012-11-26 2017-09-29 Gambro Lundia Ab Urządzenie adsorbujące łączące granulki i membrany z włókien kanalikowych
EP2735359B1 (en) 2012-11-26 2017-02-08 Gambro Lundia AB Integrated device for liver support systems
US12558316B2 (en) 2013-03-13 2026-02-24 University Of Miami Methods and compositions for the treatment of epidermolysis bullosa
WO2014159662A1 (en) 2013-03-13 2014-10-02 University Of Miami Method for isolation and purification of microvesicles from cell culture supernatants and biological fluids
WO2014140884A2 (en) * 2013-03-15 2014-09-18 Novelogics Biotechnology, Inc. Methods and devices for removal of immunosuppressive ligands
CN105980615A (zh) 2013-08-28 2016-09-28 卡里斯生命科学瑞士控股有限公司 寡核苷酸探针及其用途
JP6621414B2 (ja) * 2014-01-30 2019-12-18 フレゼニウス・ヘモケア・イタリア・ソシエタ・ア・レスポンサビリタ・リミタータＦＲＥＳＥＮＩＵＳ ＨＥＭＯＣＡＲＥ ＩＴＡＬＩＡ Ｓ．ｒ．ｌ． 濾過装置
CN106030304B (zh) 2014-02-27 2018-02-06 得克萨斯大学体系董事会 用于分离外来体的方法和组合物
US20170165334A1 (en) * 2015-12-11 2017-06-15 Tianxin Wang Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification
WO2016145128A1 (en) 2015-03-09 2016-09-15 Caris Science, Inc. Oligonucleotide probes and uses thereof
EP3287137B1 (en) 2015-03-12 2021-05-05 Mitsui Chemicals, Inc. Method for disrupting exosomes, exosome disruption kit, and method for separating exosomes derived from normal cells
EP3314027A4 (en) 2015-06-29 2019-07-03 Caris Science, Inc. THERAPEUTIC OLIGONUCLEOTIDES
US10941176B2 (en) 2015-07-28 2021-03-09 Caris Science, Inc. Therapeutic oligonucleotides
EP3246703A1 (en) 2016-05-20 2017-11-22 Unicyte EV AG Method and kit for capturing extracellular vesicles (evs) on a solid surface
WO2018071681A1 (en) 2016-10-13 2018-04-19 Vbc Holdings Llc Cancer stem cell exosomes
CN111133106A (zh) 2017-07-12 2020-05-08 外来体诊断公司 用于分离和富集生物流体来源的细胞外囊泡的方法及其使用方法
WO2019053243A1 (en) 2017-09-18 2019-03-21 Santersus Sa METHOD AND DEVICE FOR PURIFYING BLOOD OF FREE CIRCULATING DNA
EP3684383A4 (en) * 2017-09-20 2021-07-14 Molecular Stethoscope, Inc. METHODS AND SYSTEMS FOR DETECTION OF TISSUE DISORDERS
JP7429343B2 (ja) 2018-01-05 2024-02-08 パス イーエックス，インク． 流体からの疾患材料の捕捉および除去のためのデバイス
JP7337438B2 (ja) * 2018-03-30 2023-09-04 エクソソミクス・ソシエタ・ペル・アチオニ 血球および血小板由来の細胞外小胞を困窮化させた血液または血液誘導体を得るための中空糸の使用
AU2019362006A1 (en) * 2018-10-17 2021-05-20 ImMutriX Therapeutics, Inc. Adsorption and binding of plasma molecules and particles to carbon
AU2020231463B2 (en) * 2019-03-06 2025-10-09 Gambro Lundia Ab Blood treatment device comprising alkaline phosphatase
AU2020307303A1 (en) * 2019-06-27 2022-01-27 Bioimmunate Technologies Ltd. Filter for removal of multiple sclerosis-associated T-cells
WO2021211351A1 (en) 2020-04-12 2021-10-21 Aethlon Medical, Inc. Devices and methods for treating a coronavirus infection and symptoms thereof
WO2021211772A1 (en) 2020-04-14 2021-10-21 Cytosorbents Corporation Improved immune response and decreased immunoparalysis with immunomodulating treatment
WO2021221636A1 (en) * 2020-04-29 2021-11-04 Orth Consulting, Llc Blood processing apparatus and method for detoxifying bacterial lipopolysaccharide
US11103628B1 (en) * 2020-04-29 2021-08-31 Orth Consulting, Llc Blood processing apparatus and method for detoxifying bacterial lipopolysaccharide
US10881781B1 (en) 2020-04-29 2021-01-05 Orth Consulting, Llc Blood processing apparatus and method for detoxifying bacterial lipopolysaccharide
USD952157S1 (en) 2020-06-19 2022-05-17 Qualigen Inc. Whole blood treatment cartridge
JP7839784B2 (ja) * 2020-09-21 2026-04-02 ベルジアン ボリション エスアールエル 血液中の遊離ヌクレオソームのインラインモニタリングのための装置
US11224858B1 (en) 2020-10-01 2022-01-18 Immunicom, Inc. Reduced leaching of a ligand
WO2022071960A1 (en) * 2020-10-01 2022-04-07 Immunicom, Inc. Reduced leaching of a ligand
US11319520B1 (en) * 2021-09-21 2022-05-03 Upside Foods, Inc. Filter cake-based systems and methods for the cultivation of cells and cell biomass
WO2023126672A1 (en) 2021-12-27 2023-07-06 Santersus Ag Method and device for removal of circulating cell free dna
CA3247584A1 (en) * 2022-04-06 2023-10-12 Grifols Worldwide Operations Limited BLOOD FRACTIONS DEPENDED IN EXTRACELLULAR VESICLES
US12605498B2 (en) * 2022-08-31 2026-04-21 Hanuman Pelican, Inc. Apparatus and methods for extracellular vesicle enrichment
WO2024072901A1 (en) * 2022-09-28 2024-04-04 Sigyn Therapeutics, Inc. System and methods to enhance chemotherapy delivery and reduce toxicity
GB202405785D0 (en) * 2024-04-24 2024-06-05 Vesalic Ltd A method of suppressing a neurological disorder

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925152A (en) 1971-06-18 1975-12-09 Exploaterings Ab Tbf Virus separation
US4787974A (en) 1981-06-29 1988-11-29 Ambrus Clara M Blood purification
US4714556A (en) 1981-06-29 1987-12-22 Ambrus Clara M Blood purification
US4708713A (en) * 1984-11-16 1987-11-24 Anisa Medical, Inc. Method and system for removing immunosuppressive components from the blood of mammals
US5782792A (en) * 1986-11-21 1998-07-21 Cypress Bioscience, Inc. Method for treatment of rheumatoid arthritis
US5041079A (en) 1987-12-04 1991-08-20 Kuraray Co., Ltd. Method for removing human immunodeficiency virus and/or its related compounds
US5567588A (en) * 1990-06-11 1996-10-22 University Research Corporation Systematic evolution of ligands by exponential enrichment: Solution SELEX
US5268275A (en) * 1991-05-08 1993-12-07 The University Of North Carolina At Chapel Hill Vitamin K-dependent carboxylase
US5861310A (en) * 1993-11-03 1999-01-19 Dana-Farber Cancer Institute Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor
JP3615785B2 (ja) 1994-04-28 2005-02-02 テルモ株式会社 Ｈｉｖ及びその関連物質除去材料
CA2215905A1 (en) 1995-03-20 1996-09-26 Sumitomo Electric Industries, Ltd. Monoclonal antibody reacting specifically with fas ligand and process for producing the same
US6620382B1 (en) * 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
AU4827999A (en) * 1998-06-24 2000-01-10 Chen & Chen, Llc Multi-layer testing column
ATE318176T1 (de) 1998-08-31 2006-03-15 Julian L Ambrus Verfahren zur entfernung von hiv und anderen viren aus blut
US20040214783A1 (en) * 2002-05-08 2004-10-28 Terman David S. Compositions and methods for treatment of neoplastic disease
GB9927320D0 (en) * 1999-11-18 2000-01-12 Chiron Spa Exosome separation
US7572631B2 (en) * 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
US6812023B1 (en) * 2000-04-27 2004-11-02 Anosys, Inc. Methods of producing membrane vesicles
IL160142A0 (en) * 2001-08-17 2004-06-20 Anosys Inc Methods and compounds for the targeting of protein to exosomes
EP1483372A2 (en) * 2002-03-14 2004-12-08 Anosys, Inc. Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions
WO2004064608A2 (en) * 2003-01-17 2004-08-05 Aethlon Medical, Inc. Method for removal of viruses from blood by lectin affinity hemodialysis
CA2453198A1 (en) * 2004-01-07 2005-07-07 Wei-Ping Min Quantification and generation of immune suppressive exosomes
JP5068543B2 (ja) * 2004-02-16 2012-11-07 プロテオジス アクチェンゲゼルシャフト がんに関する診断マーカー
JP2008511340A (ja) * 2004-04-30 2008-04-17 バイオフェレシス テクノロジーズ， インコーポレイテッド 患者において可溶性ｔｎｆｒ１、可溶性ｔｎｆｒ２、および可溶性ｉｌ２を除去する方法およびシステム
US8021847B2 (en) * 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
US20060116321A1 (en) * 2004-07-01 2006-06-01 Robbins Paul D Immunosuppressive exosomes
JP4029298B2 (ja) * 2004-07-26 2008-01-09 大塚製薬株式会社 粘着性マイクロベシクルの除去方法
EP1776582B1 (de) 2004-07-30 2020-06-24 pluriSelect Life Sciences UG & Co. KG Vorrichtung und verfahren zum isolieren von zellen, biopartikeln und/oder molekülen aus flüssigkeiten mit dem ziel einer anwendung für tiere, in der biotechnologie (einschliesslich der biologischen forschung) und der medizinischen diagnostik
CA2504279A1 (en) * 2005-04-15 2006-10-15 University Of Saskatchewan Materials and method of modulating the immune response using t helper-antigen presenting cells
AU2006243905B2 (en) * 2005-05-13 2011-09-01 The Feinstein Institute For Medical Research Milk fat globule epidermal growth factor-factor VIII and sepsis
WO2007015174A2 (en) * 2005-07-08 2007-02-08 Exothera L.L.C. Exosome-specific ligands, their preparartion and uses
WO2007047907A2 (en) * 2005-10-14 2007-04-26 The Regents Of The University Of Michigan Dek protein compositions and methods of using the same
WO2007064859A2 (en) * 2005-11-29 2007-06-07 University Of Pittsburgh Of The Commonwealth System Of Higher Education Compound and method for suppressing retroviral replication
DK3517151T3 (da) * 2006-03-09 2021-07-12 Aethlon Medical Inc Ekstrakorporal fjernelse af mikrovesikulære partikler
CN101641010A (zh) * 2007-01-26 2010-02-03 路易斯维尔大学研究基金会公司 用作疫苗的外来体组分的修饰
US20090104649A1 (en) * 2007-06-11 2009-04-23 Garovic Vesna D Markers for preeclampsia
CA2676113C (en) * 2007-07-25 2014-07-08 University Of Louisville Research Foundation, Inc. Exosome-associated microrna as a diagnostic marker
JP5563472B2 (ja) * 2007-11-28 2014-07-30 アイ アール エックス セーラピューティクス， インコーポレイテッド 免疫学的効果を増大させる方法
KR101810799B1 (ko) * 2008-02-01 2017-12-19 더 제너럴 하스피탈 코포레이션 의학적 질환 및 병태의 진단, 예후, 및 치료에 있어서 미세소포체의 용도
WO2011009104A1 (en) * 2009-07-16 2011-01-20 The General Hospital Corporation Nucleic acid analysis
WO2010056337A2 (en) * 2008-11-12 2010-05-20 Caris Mpi, Inc. Methods and systems of using exosomes for determining phenotypes
WO2010065765A2 (en) * 2008-12-04 2010-06-10 Aethlon Medical, Inc. Affinity capture of circulating biomarkers
CA2782284A1 (en) * 2009-11-30 2011-06-03 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Methods and systems for isolating, storing, and analyzing vesicles
CN102753974A (zh) * 2010-02-11 2012-10-24 勒芬天主教大学 磷脂轮廓分析和癌症
ES2624284T3 (es) * 2010-07-07 2017-07-13 Aethlon Medical Inc Métodos para cuantificar exosomas

Also Published As

Publication number Publication date
US20130015118A1 (en) 2013-01-17
US9364601B2 (en) 2016-06-14
US8288172B2 (en) 2012-10-16
CA3061952A1 (en) 2007-09-13
CA2644855C (en) 2019-11-19
EP1993600A4 (en) 2014-02-19
WO2007103572A3 (en) 2008-09-12
EP1993600B1 (en) 2019-04-24
ES2736726T3 (es) 2020-01-07
ES2880460T3 (es) 2021-11-24
US20140166578A1 (en) 2014-06-19
EP3517151A1 (en) 2019-07-31
US20090304677A1 (en) 2009-12-10
EP1993600A2 (en) 2008-11-26
CA2644855A1 (en) 2007-09-13
CA3061952C (en) 2022-07-19
WO2007103572A2 (en) 2007-09-13
EP3517151B1 (en) 2021-04-21
US20140161810A1 (en) 2014-06-12
US9707333B2 (en) 2017-07-18

Similar Documents

Publication Publication Date Title
DK3517151T3 (da) Ekstrakorporal fjernelse af mikrovesikulære partikler
DK1986633T3 (da) Behandling af duchennes muskeldystrofi
DE602007008139D1 (de) Trennverfahren
DK2700786T3 (da) Modifikation af overførselspassage
DK2111555T3 (da) Diagnosticering af præeklampsi
DK2144498T3 (da) Akustisk bortskræmning
DK2097402T3 (da) Makrocykliske inhibitorer af hepatitis c-virus
EP2200734A4 (en) REMOVAL OF AMMONIA FROM FLUIDS
DE602008002009D1 (de) Elektrostatische Klammer
DK2219469T3 (da) Modificering af enzymatisk disponerede proteiner
DE602007011436D1 (de) Lufttrennverfahren
EP1984323A4 (en) VIRAL POLYMERASE INHIBITORS
DK2178900T3 (da) Oprensning af pegylerede polypeptider
DK2114147T3 (da) Reduktion af bivirkninger af tramadol
BRPI0819628A2 (pt) partículas anticorrosivas
DK1867900T3 (da) Adskillelseselement
DK2084207T3 (da) Stabile laktidpartikler
DE602007010428D1 (de) Teilcheneingeschlossener nanoschalter
DK1739093T3 (da) Separation af plasmaproteiner
DK2190451T3 (da) Behandling af atherosklerose
DK2077913T3 (da) Fremgangsmåde til regenerering af filterhjælpemiddel
EP2156837A4 (en) PARTICLES OF CRYSTALLINE MICROPOUDER
NO20062207L (no) Elektrostatisk koalescer
DK2070602T3 (da) Partikelsepareringsanordning
DK2242479T3 (da) Modtryksfiltrering af proteiner